Antibiotic Susceptibility Testing in Urine Cultures

Interpretation of MIC Values

For susceptible organisms (low MICs like <0.12 μg/mL), standard treatment regimens are appropriate, with 7-14 days of appropriate antibiotics for complicated UTIs, as recommended by the European Urology guidelines 1
A MIC value less than 2 μg/mL generally indicates that the microorganism is susceptible to the antibiotic, according to the breakpoints established by the Clinical Laboratory Standards Institute (CLSI) or the European Committee on Antimicrobial Susceptibility Testing (EUCAST) 2, 3
The following table summarizes the MIC interpretation breakpoints:

MIC (mcg/mL)	Interpretation
≤0.5	Susceptible
>0.5	Intermediate/Resistant

For most common pathogens, an MIC ≤0.5 mcg/mL falls well within the susceptible range for many antibiotics, as reported by the Morbidity and Mortality Weekly Report 4
A MIC value less than 2 μg/mL is a favorable indicator of the potential efficacy of the antibiotic against the pathogen, guiding towards a higher probability of therapeutic success when using the appropriate dosage, as stated in the Clinical Microbiology and Infection journal 2, 5

The European Urology guidelines recommend adjusting dosing based on renal function for complicated UTIs, although the exact details are not provided in this context 1
When treating complicated UTIs, it is essential to consider pharmacokinetics/pharmacodynamics, infection site, and host factors, such as immunosuppression, renal/hepatic insufficiency, which may affect outcomes 1
For time-dependent antibiotics (such as beta-lactams), it is recommended to maintain free plasma concentrations 4-8 times above the MIC throughout the dosing interval, as recommended by the American College of Clinical Pharmacology and the Infectious Diseases Society of America 6, 5
For concentration-dependent antibiotics (such as aminoglycosides and fluoroquinolones), it is recommended to maximize the peak concentration/MIC ratio or the area under the concentration-time curve (AUC)/MIC ratio, as suggested by the European Society of Clinical Microbiology and Infectious Diseases and the American Academy of Otolaryngology-Head and Neck Surgery 6, 5

MIC values alone do not guarantee clinical success, and it is crucial to consider factors like pharmacokinetics/pharmacodynamics, infection site, and host factors 1
Ignoring resistance mechanisms, overlooking host factors, focusing only on MIC, and misinterpreting borderline values can lead to incorrect treatment decisions 1
Overlooking resistance mechanisms, such as inducible resistance, can lead to ineffective treatment, as highlighted in the Morbidity and Mortality Weekly Report 4
Clinical response depends on multiple factors, including infection site, growth conditions, inoculum effect, and host factors, which should be considered when interpreting MIC values, as noted by the Morbidity and Mortality Weekly Report and the American Academy of Otolaryngology-Head and Neck Surgery 4, 7
Maintaining concentrations above the MIC correlates with improved outcomes, with 100% fT > MIC associated with improved clinical outcomes compared to 50% fT > MIC in septic ICU patients, as reported by the American College of Clinical Pharmacology 6
A fCmin/MIC ratio above 7.6 has been associated with bacterial eradication in 100% of patients with E. coli and Klebsiella infections, as suggested by the American College of Clinical Pharmacology 6